Steven Park, MD | Authors

Tazemetostat in R/R FL: Original Trial Data and a Propensity Score-Matched Analysis

September 29, 2022

Drs Cheson and Park briefly review previous data from the E7438-G000-101 trial on tazemetostat in patients with wild-type or EZH2-mutant R/R FL, and then describe the findings of a more recent 2022 propensity score-matched analysis of the data that was intended to address baseline clinical differences between the two patient populations.